GlassScriptPhysician profile
Nina S Pollack
NPI 1306334842
$1,597.49
in general payments reported to CMS, 2019-2025
9 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $35.12 · 2023: $425 · 2024: $905 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,562.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $347.32 | 2023-2025 | |
| Mentor Worldwide LLC | $312.67 | 2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Axogen | $226.78 | 2023-2024 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
| Integra Lifesciences Corporation | $204.93 | 2022-2024 | Durasorb Monofilament Mesh, Biodoptix, Biodfactor |
| Acera Surgical, INC. | $183.86 | 2024-2025 | Restrata Wound Matrix |
| Tela Bio, INC. | $166.55 | 2024 | Ovitex 2s |
| Ethicon US, LLC | $116.42 | 2024 | Vistaseal, Dermabond, Surgicel Nu-Knit |
| Solventum Corporation | $19.72 | 2024 | Activ.A.C., Prevena, V.A.C. Dermatac |
| Medical Device Business Services, INC. | $19.24 | 2023 | Vistaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nina Pollack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.